Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. OMI
OMI logo

OMI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
1.05B
Low
--
Amount
--
EV/EBITDA(TTM)
5.21
Total Shares
--
EV
2.30B
EV/OCF(TTM)
--
P/S(TTM)
0.02
Accendra Health, Inc., formerly Owens & Minor, Inc., is a nationwide pure play home-based care platform. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.
Show More

Events Timeline

(ET)
2025-12-18
16:10:00
Owens & Minor Renames to Accendra Health, Changes Ticker to ACH
select
2025-10-30 (ET)
2025-10-30
16:17:24
Owens & Minor reaffirms FY25 adjusted EPS forecast of $1.02-$1.07, matching consensus at $1.02
select
2025-10-30
16:16:50
Owens & Minor announces Q3 adjusted EPS of 25 cents, surpassing consensus estimate of 23 cents.
select
2025-10-07 (ET)
2025-10-07
16:27:04
Platinum to Purchase Owens & Minor's Products and Healthcare Services Division
select
2025-10-07
16:17:03
Owens & Minor to Sell Products and Healthcare Services Division for $375 Million
select
2025-09-22 (ET)
2025-09-22
04:55:00
S&P Dow Jones Indices Reveals Quarterly Rebalancing Update
select
2025-09-05 (ET)
2025-09-05
17:29:12
S&P Dow Jones Indices Reveals Quarterly Rebalancing Update
select

News

Newsfilter
4.5
2025-12-31Newsfilter
Owens & Minor Sells P&HS Segment for $375 Million, Becomes Accendra Health
  • Strategic Transformation Completed: Owens & Minor has successfully sold its Products & Healthcare Services segment for $375 million in cash, transforming into Accendra Health, a focused player in the home-based care market, thereby enhancing its competitive edge in this rapidly growing sector.
  • Core Business Focus: This transaction allows the company to concentrate on its Apria and Byram brands, optimizing capital deployment and corporate strategy, which will improve operational efficiency and create long-term value to meet the home care needs of patients with chronic conditions.
  • Equity Retention and Tax Advantages: The deal includes a 5% retained equity stake and preserves tax attributes exceeding $150 million, which will support future financial flexibility and bolster investor confidence.
  • Positive Future Outlook: CEO Edward A. Pesicka stated that the new strategic direction will make Accendra Health more resilient, enabling it to better respond to market changes and seize long-term growth opportunities in the home care sector.
Newsfilter
4.5
2025-12-18Newsfilter
Owens & Minor Renames to Accendra Health, Effective January 2, 2026
  • Company Renaming: Owens & Minor will change its name to Accendra Health effective December 31, 2025, which aims to better reflect its strategic direction in the home-based care market, potentially enhancing brand recognition and market positioning.
  • Ticker Symbol Change: The new name will be accompanied by a ticker symbol change to "ACH," expected to begin trading on the New York Stock Exchange on January 2, 2026, thereby increasing investor focus on the company's future developments.
  • Ongoing Commitment: CEO Edward A. Pesicka emphasized that despite the renaming, the commitment to providing high-quality services remains unchanged, which will help maintain customer trust and drive long-term profitable growth.
  • New Website Launch: Coinciding with the renaming, the company will launch its new website www.accendrahealth.com, further enhancing its online brand presence and customer engagement to support future market expansion.
NASDAQ.COM
8.0
2025-12-05NASDAQ.COM
Are Options Traders Aware of Insights About Owens & Minor Stock That We Are Not?
  • Implied Volatility in Options Market: Investors should monitor Owens & Minor, Inc. (OMI) as the Dec 19, 2025 $25.00 Call shows high implied volatility, indicating expectations of significant stock movement, possibly due to an upcoming event.

  • Analyst Sentiment: Owens & Minor currently holds a Zacks Rank #5 (Strong Sell) in the Medical-Products Industry, with no analysts increasing estimates for the current quarter and two revising them downward, leading to a consensus estimate drop from 24 cents to 22 cents per share.

  • Options Trading Strategy: The high implied volatility may signal a trading opportunity, as seasoned options traders often seek to sell premium on such options, hoping the stock does not move as much as anticipated by expiration.

  • Technological Investment Opportunities: The article highlights the potential of artificial intelligence and quantum computing in reshaping investment landscapes, suggesting that early investors in certain stocks could benefit significantly from this technological revolution.

Newsfilter
1.0
2025-12-02Newsfilter
Owens & Minor Management to Attend Two Investor Conferences
  • Conference Participation: Owens & Minor's management team is scheduled to participate in the Citi 2025 Global Healthcare Conference on December 2, 2025, where CEO Ed Pesicka and VP Will Parrish will engage in a fireside chat at 2:30 PM ET, likely drawing significant investor interest.
  • One-on-One Meetings: On the same day, CFO Jon Leon and VP of Tax & Treasury Alex Miller will host one-on-one investor meetings in Boca Raton, Florida, aimed at enhancing direct communication with investors.
  • Company Overview: Owens & Minor is a Fortune 500 global healthcare solutions company providing essential products and services that support care from hospital to home, powered by over 20,000 employees dedicated to improving daily experiences for patients and providers.
  • Brand Influence: The company’s affiliated brands, including Apria, Byram, and HALYARD, focus on delivering comfort and confidence in the healthcare sector, showcasing its significant position in the global healthcare market.
Benzinga
6.0
2025-11-03Benzinga
Charter Communications Analyst Changes Stance; Check Out the Top 5 Downgrades for Monday
  • Analyst Downgrades: UBS analyst Kevin Caliendo downgraded Owens & Minor, Inc. from Buy to Neutral, lowering the price target from $7 to $4, with shares closing at $3.97.

  • Marsh & McLennan Companies: B of A Securities analyst Joshua Shanker downgraded Marsh & McLennan from Neutral to Underperform, reducing the price target from $243 to $181, as shares closed at $178.15.

  • Charter Communications: Keybanc analyst Brandon Nispel downgraded Charter Communications from Overweight to Sector Weight, with shares closing at $233.84.

  • Rigetti Computing and Canadian Solar: B. Riley Securities downgraded Rigetti Computing from Buy to Neutral, raising the price target from $35 to $42, while Jefferies downgraded Canadian Solar from Buy to Hold, increasing the price target from $13.7 to $19.64.

SeekingAlpha
2.0
2025-10-08SeekingAlpha
Major Stock Movers on Wednesday: JOBY, OMI, and Others
  • Stock Market Overview: Stock futures rose as investors anticipated Federal Reserve minutes for insights on policy direction amidst a government shutdown affecting economic data.

  • Owens & Minor Gains: Shares of Owens & Minor increased by 2% after announcing the sale of its Products & Healthcare Services segment for $375M, while retaining a 5% stake in the business.

  • Esperion Therapeutics Decline: Esperion Therapeutics saw an 18% drop in shares following the announcement of a public offering of 30M shares at $2.50 each, aiming to raise $75M.

  • Joby Aviation and Iris Energy Losses: Joby Aviation's shares fell by 9% after pricing a $514M stock offering, while Iris Energy's shares declined by 5% due to a proposed $875M private offering of convertible senior notes.

Wall Street analysts forecast OMI stock price to rise
3 Analyst Rating
Wall Street analysts forecast OMI stock price to rise
0 Buy
2 Hold
1 Sell
Moderate Sell
Current: 0.000
sliders
Low
4.00
Averages
4.90
High
6.00
Current: 0.000
sliders
Low
4.00
Averages
4.90
High
6.00
UBS
Buy
to
Neutral
downgrade
$7 -> $4
AI Analysis
2025-11-03
Reason
UBS
Price Target
$7 -> $4
AI Analysis
2025-11-03
downgrade
Buy
to
Neutral
Reason
UBS downgraded Owens & Minor to Neutral from Buy with a price target of $4, down from $7. The firm cites the company's limited earnings visibility and longer cash flow turnaround for the downgrade. UBS does not expect Owens & Minor's EBITDA to grow in 2026 given the Kaiser loss and higher stranded costs. The company's cash flow will not recover in the near-term given working capital constraints tied to the kitting facility, the analyst tells investors in a research note.
JPMorgan
NULL -> Underweight
downgrade
$7 -> $6
2025-08-27
Reason
JPMorgan
Price Target
$7 -> $6
2025-08-27
downgrade
NULL -> Underweight
Reason
JPMorgan lowered the firm's price target on Owens & Minor to $6 from $7 and keeps an Underweight rating on the shares. The firm updated the company's model.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OMI
Unlock Now

Valuation Metrics

The current forward P/E ratio for Accendra Health Inc (OMI.N) is 3.40, compared to its 5-year average forward P/E of 10.70. For a more detailed relative valuation and DCF analysis to assess Accendra Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.70
Current PE
3.40
Overvalued PE
14.55
Undervalued PE
6.86

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
7.30
Current EV/EBITDA
6.71
Overvalued EV/EBITDA
8.95
Undervalued EV/EBITDA
5.65

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.18
Current PS
0.08
Overvalued PS
0.27
Undervalued PS
0.09

Financials

AI Analysis
Annual
Quarterly

Whales Holding OMI

P
Paradigm Capital Management, Inc.
Holding
OMI
+4.67%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Accendra Health Inc (OMI) stock price today?

The current price of OMI is 0 USD — it has increased 0

What is Accendra Health Inc (OMI)'s business?

Accendra Health, Inc., formerly Owens & Minor, Inc., is a nationwide pure play home-based care platform. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.

What is the price predicton of OMI Stock?

Wall Street analysts forecast OMI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMI is4.90 USD with a low forecast of 4.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Accendra Health Inc (OMI)'s revenue for the last quarter?

Accendra Health Inc revenue for the last quarter amounts to 697.26M USD, increased 1.52

What is Accendra Health Inc (OMI)'s earnings per share (EPS) for the last quarter?

Accendra Health Inc. EPS for the last quarter amounts to -1.94 USD, increased 1041.18

How many employees does Accendra Health Inc (OMI). have?

Accendra Health Inc (OMI) has 13500 emplpoyees as of March 10 2026.

What is Accendra Health Inc (OMI) market cap?

Today OMI has the market capitalization of 1.05B USD.